Search Results - "DECOTEAU, J. F"

Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition by Lakshmikuttyamma, A, Scott, S A, DeCoteau, J F, Geyer, C R

“…Reexpression of hypermethylated tumor suppressor genes using DNA methyltransferase (DNMT) and histone deacetylase inhibitors occurs by a mechanism whereby…”
Get full text

Bcr-Abl induces autocrine IGF-1 signaling by Lakshmikuttyamma, A, Pastural, E, Takahashi, N, Sawada, K, Sheridan, D P, DeCoteau, J F, Geyer, C R

“…Bcr-Abl oncogene is responsible for the initial phase of chronic myelogenous leukemia (CML), which is effectively treated by the Bcr-Abl inhibitor imatinib…”
Get full text

RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines by PASTURAL, E, TAKAHASHI, N, DONG, W.-F, BAINBRIDGE, M, HULL, A, PEARSON, D, HUANG, S, LOWSKY, R, DECOTEAU, J. F, GEYER, C. R

“…RIZ1 is a histone methyltransferase whose expression and activity are reduced in many cancers. In chronic myelogenous leukemia (CML), blastic transformation is…”
Get full text

The t(2;5) Chromosomal Translocation Is Not a Common Feature of Primary Cutaneous CD30+ Lymphoproliferative Disorders: Comparison With Anaplastic Large-Cell Lymphoma of Nodal Origin by DeCoteau, John F., Butmarc, Janet R., Kinney, Marsha C., Kadin, Marshall E.

“…Primary cutaneous CD30+ lymphoproliferative disorders (LPDs), including lymphomatoid papulosis (LyP), anaplastic and nonanaplastic CD30+ large-cell lymphoma,…”
Get full text

A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma by Knaus, Petra I., Lindemann, Dirk, DeCoteau, John F., Perlman, Riki, Yankelev, Haya, Hille, Merrill, Kadin, Marshall E., Lodish, Harvey F.

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance by Truitt, L, Hutchinson, C, DeCoteau, J F, Geyer, C R

“…Chronic myelogenous leukemia (CML) is maintained by a minor population of leukemic stem cells (LSCs) that exhibit innate resistance to tyrosine kinase…”
Get full text

Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus : A case report and review of the literature by ICHINOHASAMA, R, MIURA, I, KOBAYASHI, N, SAITOH, Y, DECOTEAU, J. F, SAIKI, Y, MORI, S, KADIN, M. E, OOYA, K

“…At present, there is no case report of HHV8- primary effusion lymphoma (PEL) with t(9;14)(p13;q32) involving both PAX-5 and immunoglobulin heavy chain gene…”
Get full text

Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues by Zhao, Ronghua, DeCoteau, John F., Geyer, C.Ronald, Gao, Mei, Cui, Hengmi, Casson, Alan G.

“…To evaluate loss of imprinting (LOI) and expression of the IGF2 gene in matched esophageal normal and adenocarcinoma tissues, we studied a prospective cohort…”
Get full text

Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL) by LOWSKY, R, DECOTEAU, J. F, REITMAIR, A. H, ICHINOHASAMA, R, DONG, W.-F, XU, Y, MAK, T. W, KADIN, M. E, MINDEN, M. D

“…Mutations in the DNA mismatch repair (MMR) gene hMSH2 underlie a novel pathway of tumorigenesis for some cancers of epithelial origin. Mice deficient in MSH2…”
Get full text

Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis : report of two cases and review of the literature by ICHINOHASAMA, R, MIURA, I, KADIN, M. E, OOYA, K, TAKAHASHI, N, SUGAWARA, T, TAMATE, E, ENDOH, K, ENDOH, F, NAGANUMA, H, DECOTEAU, J. F, GRIFFIN, J. D

“…This report describes two cases of Philadelphia chromosome-negative (Ph(-)) non-Hodgkin's lymphomas (NHLs) recognized in patients with chronic phase…”
Get full text

Yeast two-hybrid screening of cyclic peptide libraries using a combination of random and PI-deconvolution pooling strategies by Barreto, K., Aparicio, A., Bharathikumar, V.M., DeCoteau, J.F., Geyer, C.R.

“…We developed a high throughput yeast two-hybrid (Y2H) assay for screening pools of combinatorial cyclic peptide preys against pools of bait proteins. The assay…”
Get full text

Three-color flow cytometry in the diagnosis of malignant lymphoma based on the comparative cell morphology of lymphoma cells and reactive lymphocytes by ICHINOHASAMA, R, DECOTEAU, J. F, MYERS, J, KADIN, M. E, SAWAI, T, OOYA, K

“…This study examines the identification of unusual cell populations highly associated with lymphoma cells (UCP-L) in diagnostic biopsy specimens using…”
Get full text

Cortical Blindness as a Manifestation of Hypomagnesemia Secondary to Cisplatin Therapy: Case Report and Review of Literature by Al-Tweigeri, Taher, Magliocco, Anthony M., DeCoteau, John F.

“…Cisplatin is widely used in the treatment of solid tumors and is known to have a number of side effects including hypomagnesemia. We present a case report of a…”
Get full text

A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation by Ott, German, Bastian, Boris C., Katzenberger, Tiemo, Decoteau, John F., Kalla, Jörg, Rosenwald, Andreas, Weissinger, Florian, Ott, M. Michaela, Kadin, Marshall E., Müller‐Hermelink, Hans K.

“…Cytogenetic investigations were performed in a case of a nodal malignant non‐Hodgkin's lymphoma. Histopathological analysis from an involved lymph node as well…”
Get full text

Epitope Mapping of the Major Epstein-Barr Virus Outer Envelope Glycoprotein gp350/220 by Qualtiere, Louis F, Decoteau, John F, Nasr-El-Din, Mona Hassan

“…* Immunovirology Research Group, Department of Microbiology, Health Sciences Building, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 0W0 To…”
Get full text

SBH-1, a Novel Reed-Sternberg-Like Cell Line Capable of Inducing Tumors in SCID Mice: Immunophenotypic, Cytogenetic, and Cytokine Expression Profiles by DeCoteau, John F., Reis, Marciano D., Griesser, Henrik, Lorenzana, Adonis, Al-Hashmi, Ibrahim, Hawley, Robert G., Naumov, Adriana, White, Christine A., Pinkerton, Peter H.

“…A new cell line, SBH-1, with the morphologic, immunophenotypic, and karyotypic features consistent with those of Reed-Sternberg (RS) and Hodgkin (H) cells, has…”
Get full text

Loss of Functional Cell Surface Transforming Growth Factor β (TGF-β ) Type 1 Receptor Correlates with Insensitivity to TGF-β in Chronic Lymphocytic Leukemia by DeCoteau, John F., Knaus, Petra I., Yankelev, Haya, Reis, Marciano D., Lowsky, Robert, Lodish, Harvey F., Kadin, Marshall E.

“…Chronic lymphocytic leukemia (CLL) is the most common form of adult leukemia in Western countries, and there is significant variability in survival within CLL…”
Get full text

The replication error phenotype is associated with the development of distant metastases in hormonally treated patients with breast carcinoma by Chagpar, Anees, Magliocco, Anthony, Kerviche, Annette, Tan, Leonard, Walley, Barbara, DeCoteau, John F.

“…BACKGROUND The positive replication error (RER+) phenotype defines a distinct subgroup of tumors with specific clinical, pathologic, and molecular features…”
Get full text

Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia by Scott, Stuart A., Kimura, Tomofumi, Dong, Wei-Feng, Ichinohasama, Ryo, Bergen, Susan, Kerviche, Annette, Sheridan, David, DeCoteau, John F.

“…Epigenetic silencing of downstream components of the transforming growth factor beta pathway including the cyclin-dependent kinase inhibitors (CDKIs) p15INK4B,…”
Get full text

Microsatellite mutations of transforming growth factor-β receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation by Scott, Stuart, Kimura, Tomofumi, Ichinohasama, Ryo, Bergen, Susan, Magliocco, Anthony, Reimer, Cara, Kerviche, Annette, Sheridan, David, DeCoteau, John F.

“…In solid cancers, defective DNA mismatch repair (MMR) is most commonly caused by hMSH2 or hMLH1 mutations, or epigenetic silencing of hMLH1 by promoter…”
Get full text